Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$34.5 - $42.19 $13.1 Million - $16 Million
-378,318 Reduced 82.98%
77,622 $3.27 Million
Q1 2023

May 11, 2023

BUY
$33.32 - $40.98 $14.1 Million - $17.3 Million
423,221 Added 1293.5%
455,940 $16.2 Million
Q4 2022

Feb 09, 2023

BUY
$25.32 - $51.45 $40,005 - $81,291
1,580 Added 5.07%
32,719 $1.2 Million
Q3 2022

Nov 10, 2022

BUY
$46.5 - $79.14 $626,076 - $1.07 Million
13,464 Added 76.18%
31,139 $1.47 Million
Q2 2022

Aug 10, 2022

SELL
$63.06 - $84.75 $68,735 - $92,377
-1,090 Reduced 5.81%
17,675 $1.27 Million
Q1 2022

May 12, 2022

SELL
$74.15 - $99.36 $35,147 - $47,096
-474 Reduced 2.46%
18,765 $1.52 Million
Q4 2021

Feb 10, 2022

SELL
$86.01 - $102.89 $637,592 - $762,723
-7,413 Reduced 27.81%
19,239 $1.98 Million
Q3 2021

Nov 10, 2021

BUY
$84.7 - $96.31 $2.26 Million - $2.57 Million
26,652 New
26,652 $2.33 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.